Form 4 for HIMS Hims & Hers Health, Inc.
Accepted 2021-08-06 00:00:00 ET · period of report 2021-08-06 · accession 0000899243-21-031998 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2021-08-06 | 2021-08-06 | HIMS | Dudum Andrew | CEO, Dir, 10% | F - Tax | — | -33.9K | 8.28M | -0.4% | — |
| DI | 2021-08-06 | 2021-08-06 | HIMS | Dudum Andrew | CEO, Dir, 10% | M - OptEx | $11.50 | +46.2K | 8.31M | +0.6% | +$531.7K |
| DI | 2021-08-06 | 2021-08-06 | HIMS | Dudum Andrew | CEO, Dir, 10% | M - OptEx | $0.00 | -46.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-08-06 | F | D | 33,893 | — | 8,280,910 | I Held by Atomic Labs II, L.P. | — | — | (F1) Atomic Labs II, L.P. exercised warrants to purchase shares of the Issuer's Class A Common Stock. The warrants were exercised on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, Atomic Labs II, L.P. received 0.267 shares per warrant exercised and the Issuer withheld 0.733 shares per warrant exercised. The exercise of the warrants, the withholding of shares of Class A Common Stock in the cashless exercise and the resulting issuance of the net shares of Class A Common Stock were exempt under Rule 16b-3 of the Securities Exchange Act of 1934, as amended. (F3) Mr. Dudum is a managing member of Atomic GP II, LLC, the general partner and manager of Atomic Labs II, L.P. Mr. Dudum may be deemed the beneficial owner of the shares held by Atomic Labs II, L.P., but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein. |
| 2 | Common | Class A Common Stock | 2021-08-06 | M | A | 46,238 | $11.50 | 8,314,803 | I Held by Atomic Labs II, L.P. | — | — | (F3) Mr. Dudum is a managing member of Atomic GP II, LLC, the general partner and manager of Atomic Labs II, L.P. Mr. Dudum may be deemed the beneficial owner of the shares held by Atomic Labs II, L.P., but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein. |
| 3 | Derivative | Warrant (right to buy) | 2021-08-06 | M | D | 46,238 | $0.00 | 0 | I Held by Atomic Labs II, L.P. | $11.50 · 2021-01-20 to 2026-01-20 | 46,238 Class A Common Stock | (F3) Mr. Dudum is a managing member of Atomic GP II, LLC, the general partner and manager of Atomic Labs II, L.P. Mr. Dudum may be deemed the beneficial owner of the shares held by Atomic Labs II, L.P., but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein. |